{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:01:09Z","timestamp":1790676069622,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T00:00:00Z","timestamp":1632009600000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.canrad.2020.07.004","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T17:36:42Z","timestamp":1598463402000},"page":"586-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Chimioradioth\u00e9rapie concomitante des cancers des voies a\u00e9rodigestives sup\u00e9rieures. Faut-il revoir les contraintes de dose dans les organes \u00e0 risque\u00a0?"],"prefix":"10.1016","volume":"24","author":[{"given":"M.","family":"Lapeyre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Biau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Miroir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gleyzolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Racadot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Graff-Cailleaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2020.07.004_bib0345","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2011.05.036","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site","volume":"100","author":"Blanchard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0350","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93\u00a0randomised trials and 17,346\u00a0patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0355","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2020.07.004_bib0360","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2020.07.004_bib0365","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3\u00a0trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2020.07.004_bib0370","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.radonc.2015.10.014","article-title":"Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): a meta-analysis of randomized trials","volume":"118","author":"Budach","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0375","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/hed.20279","article-title":"Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)","volume":"27","author":"Bernier","year":"2005","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2020.07.004_bib0380","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.oraloncology.2019.06.001","article-title":"Role of chemotherapy in 5000\u00a0patients with head and neck cancer treated by curative surgery: a subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer","volume":"95","author":"Dauzier","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0385","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","article-title":"Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis","volume":"26","author":"Machtay","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0390","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2020.07.004_bib0395","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-8140(02)00404-8","article-title":"Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review","volume":"66","author":"Trotti","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0400","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.currproblcancer.2018.03.004","article-title":"Combined chemoradiation vs radiation therapy alone in stage-II nasopharyngeal carcinoma: a meta-analysis of the published literature","volume":"42","author":"Wang","year":"2018","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.canrad.2020.07.004_bib0405","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijrobp.2011.06.2000","article-title":"Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer","volume":"83","author":"Sanguineti","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0410","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1002\/hed.25880","article-title":"Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy","volume":"41","author":"Baudelet","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2020.07.004_bib0415","doi-asserted-by":"crossref","first-page":"E1026","DOI":"10.1002\/hed.24150","article-title":"Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy","volume":"38","author":"Huang","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2020.07.004_bib0420","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2020.07.004_bib0425","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ijrobp.2012.05.008","article-title":"Long-term follow-up of the RTOG 9501\/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck","volume":"84","author":"Cooper","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0430","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ijrobp.2010.03.033","article-title":"Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III\/IV squamous cell carcinoma of the head and neck","volume":"80","author":"Rades","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0435","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ijrobp.2006.05.060","article-title":"Is there a \u201cmucosa-sparing\u201d benefit of IMRT for head-and-neck cancer?","volume":"66","author":"Sanguineti","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0440","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijrobp.2009.10.057","article-title":"Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer","volume":"79","author":"Sanguineti","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0445","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2008.12.011","article-title":"Mucositis versus tumor control: the therapeutic index of adding chemotherapy to irradiation of head and neck cancer","volume":"75","author":"Lee","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0450","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clon.2010.08.007","article-title":"Correlation of currently used radiobiological parameters with local control and acute and late mucosal toxicity in randomised studies of altered fractionation for locally advanced head and neck cancer","volume":"23","author":"Hartley","year":"2011","journal-title":"Clin Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0455","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijrobp.2009.05.007","article-title":"Modeling the contribution of synchronous chemotherapy to the rate of grade 3\u00a0and 4\u00a0mucositis in locally advanced squamous cell carcinoma of the head and neck","volume":"75","author":"Hartley","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0460","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.clon.2009.10.004","article-title":"Radiobiological modelling of the therapeutic ratio for the addition of synchronous chemotherapy to radiotherapy in locally advanced squamous cell carcinoma of the head and neck","volume":"22","author":"Hartley","year":"2010","journal-title":"Clin Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0465","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3109\/0284186X.2013.824609","article-title":"Factors associated with acute and late dysphagia in the DAHANCA 6 & 7\u00a0randomized trial with accelerated radiotherapy for head and neck cancer","volume":"52","author":"Mortensen","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0470","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.radonc.2013.06.001","article-title":"Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters","volume":"107","author":"Mortensen","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0475","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.canrad.2016.06.004","article-title":"Radioth\u00e9rapie conformationnelle avec modulation d\u2019intensit\u00e9 des cancers des voies a\u00e9rodigestives sup\u00e9rieures\u00a0: dose de tol\u00e9rance des tissus sains. Muscles constricteurs du pharynx et larynx","volume":"20","author":"Graff","year":"2016","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"10.1016\/j.canrad.2020.07.004_bib0480","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/hed.25688","article-title":"Dysphagia optimized radiotherapy to reduce swallowing dysfunction severity in patients undergoing treatment for head and neck cancer: a systematized scoping review","volume":"41","author":"Hutchison","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2020.07.004_bib0485","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijrobp.2009.02.017","article-title":"Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck","volume":"76","author":"Caudell","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0490","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hed.23963","article-title":"Risk factors for late dysphagia after (chemo)radiotherapy for head and neck cancer: a systematic methodological review","volume":"38","author":"Jiang","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2020.07.004_bib0495","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.radonc.2017.08.022","article-title":"Prognostic factors for tube feeding dependence after curative (chemo-) radiation in head and neck cancer: a systematic review of literature","volume":"126","author":"Wopken","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0500","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0505","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.ijrobp.2009.03.079","article-title":"Radiation dose-volume effects in the larynx and pharynx","volume":"76","author":"Rancati","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0510","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ijrobp.2009.04.087","article-title":"NTCP modeling of subacute\/late laryngeal edema scored by fiberoptic examination","volume":"75","author":"Rancati","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0515","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijrobp.2008.02.048","article-title":"Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy","volume":"72","author":"Caglar","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0520","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ijrobp.2007.01.010","article-title":"Dosimetric predictors of laryngeal edema","volume":"68","author":"Sanguineti","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0525","doi-asserted-by":"crossref","first-page":"i69","DOI":"10.1093\/jrr\/rrw047","article-title":"IMRT for head and neck cancer: reducing xerostomia and dysphagia","volume":"57","author":"Wang","year":"2016","journal-title":"J Radiat Res"},{"key":"10.1016\/j.canrad.2020.07.004_bib0530","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.canrad.2016.07.066","article-title":"Radioth\u00e9rapie conformationnelle avec modulation d\u2019intensit\u00e9 des cancers des voies a\u00e9rodigestives sup\u00e9rieures. Dose de tol\u00e9rance des tissus sains\u00a0: glandes salivaires et mandibule","volume":"20","author":"Pointreau","year":"2016","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"10.1016\/j.canrad.2020.07.004_bib0535","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0360-3016(99)00247-3","article-title":"Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer","volume":"45","author":"Eisbruch","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0540","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0360-3016(00)01441-3","article-title":"A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy\u00a0: initial results","volume":"49","author":"Chao","year":"2001","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0545","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.ijrobp.2008.12.071","article-title":"Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy","volume":"75","author":"Hey","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0550","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.radonc.2013.03.006","article-title":"The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT","volume":"106","author":"Miah","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0555","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/COC.0000000000000424","article-title":"Parameters associated with mandibular osteoradionecrosis","volume":"41","author":"Mendenhall","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0560","first-page":"1089","article-title":"Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies","volume":"18","author":"Peterson","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.canrad.2020.07.004_bib0565","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13014-016-0679-6","article-title":"Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer","volume":"11","author":"Kuhnt","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0570","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.oooo.2016.01.007","article-title":"Osteoradionecrosis following treatment for head and neck cancer and the effect of radiotherapy dosimetry: the Guy's and St Thomas\u2019 Head and Neck Cancer Unit experience","volume":"122","author":"De Felice","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0575","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tripleo.2011.07.042","article-title":"Risk factors for osteoradionecrosis after head and neck radiation: a systematic review","volume":"113","author":"Nabil","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0580","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.oraloncology.2016.11.015","article-title":"The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): the Memorial Sloan Kettering Cancer Center experience","volume":"64","author":"Owosho","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0585","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2008.12.052","article-title":"Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients","volume":"75","author":"Lee","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0590","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijrobp.2012.05.032","article-title":"Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer","volume":"85","author":"Tsai","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0595","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2017.06.026","article-title":"Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: results from a case-matched comparison","volume":"124","author":"Anderson Head","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0600","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1080\/0284186X.2019.1643037","article-title":"Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations","volume":"58","author":"Aarup-Kristensen","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0605","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.canrad.2016.07.077","article-title":"Radioth\u00e9rapie conformationnelle avec modulation d\u2019intensit\u00e9 des cancers des voies a\u00e9rodigestives sup\u00e9rieures, dose de tol\u00e9rance des tissus sains: appareil cochl\u00e9ovestibulaire et tronc c\u00e9r\u00e9bral","volume":"20","author":"Guimas","year":"2016","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"10.1016\/j.canrad.2020.07.004_bib0610","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-8140(02)00173-1","article-title":"Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation","volume":"65","author":"Honor\u00e9","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0615","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.ijrobp.2004.08.019","article-title":"Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients","volume":"61","author":"Pan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0620","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ijrobp.2008.05.040","article-title":"Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients","volume":"73","author":"Hitchcock","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0625","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hed.23551","article-title":"Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature","volume":"37","author":"Theunissen","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2020.07.004_bib0630","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.ijrobp.2008.07.034","article-title":"Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis","volume":"73","author":"Chan","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0635","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12013-014-9814-x","article-title":"Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy","volume":"69","author":"Wei","year":"2014","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0640","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.canrad.2016.08.124","article-title":"[Intensity-modulated radiotherapy of head and neck cancers. Dose constraint for spinal cord and brachial plexus]","volume":"20","author":"Boisselier","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2020.07.004_bib0645","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijrobp.2011.10.079","article-title":"Radiation dose to the brachial plexus in head-and-neck intensity-modulated radiation therapy and its relationship to tumor and nodal stage","volume":"84","author":"Truong","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0650","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4103\/jcrt.JCRT_959_17","article-title":"Dosimetric analysis and clinical outcomes of brachial plexus as an organ-at-risk in head-and-neck cancer patients treated with intensity-modulated radiotherapy","volume":"15","author":"Prakash","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.canrad.2020.07.004_bib0655","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijrobp.2011.11.019","article-title":"Brachial plexus-associated neuropathy after high-dose radiation therapy for head-and-neck cancer","volume":"84","author":"Chen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0660","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ijrobp.2013.11.244","article-title":"Dose-volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol","volume":"88","author":"Chen","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0665","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.ijrobp.2009.04.095","article-title":"Radiation dose-volume effects in the spinal cord","volume":"76","author":"Kirkpatrick","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0670","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.ijrobp.2011.10.052","article-title":"Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms","volume":"83","author":"Pak","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.07.004_bib0675","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13014-018-1015-0","article-title":"Identifying risk factors for l\u2019Hermitte's sign after IMRT for head and neck cancer","volume":"13","author":"Laidley","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2020.07.004_bib0340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00066-011-0010-2","article-title":"Lhermitte sign and myelopathy after irradiation of the cervical spinal cord in radiotherapy treatment of head and neck cancer","volume":"188","author":"Mul","year":"2012","journal-title":"Strahlenther Onkol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321820301906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321820301906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:35:19Z","timestamp":1761136519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321820301906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":68,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1278321820301906"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2020.07.004","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimioradioth\u00e9rapie concomitante des cancers des voies a\u00e9rodigestives sup\u00e9rieures. Faut-il revoir les contraintes de dose dans les organes \u00e0 risque\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2020.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}